Your browser doesn't support javascript.
loading
Cordycepin Inhibits Virus Replication in Dengue Virus-Infected Vero Cells.
Panya, Aussara; Songprakhon, Pucharee; Panwong, Suthida; Jantakee, Kanyaluck; Kaewkod, Thida; Tragoolpua, Yingmanee; Sawasdee, Nunghathai; Lee, Vannajan Sanghiran; Nimmanpipug, Piyarat; Yenchitsomanus, Pa-Thai.
Afiliação
  • Panya A; Center of Excellence for Innovation in Analytical Science and Technology, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Songprakhon P; Department of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Panwong S; Division of Molecular Medicine, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
  • Jantakee K; Department of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Kaewkod T; Department of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Tragoolpua Y; Department of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Sawasdee N; Department of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Lee VS; Division of Molecular Medicine, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
  • Nimmanpipug P; Department of Chemistry, Faculty of Science, University of Malaya, Kuala Lumpur 50603, Malaysia.
  • Yenchitsomanus PT; Center of Excellence for Innovation in Analytical Science and Technology, Chiang Mai University, Chiang Mai 50200, Thailand.
Molecules ; 26(11)2021 May 23.
Article em En | MEDLINE | ID: mdl-34071102
Dengue virus (DENV) infection causes mild to severe illness in humans that can lead to fatality in severe cases. Currently, no specific drug is available for the treatment of DENV infection. Thus, the development of an anti-DENV drug is urgently required. Cordycepin (3'-deoxyadenosine), which is a major bioactive compound in Cordyceps (ascomycete) fungus that has been used for centuries in Chinese traditional medicine, was reported to exhibit antiviral activity. However, the anti-DENV activity of cordycepin is unknown. We hypothesized that cordycepin exerts anti-DENV activity and that, as an adenosine derivative, it inhibits DENV replication. To test this hypothesis, we investigated the anti-DENV activity of cordycepin in DENV-infected Vero cells. Cordycepin treatment significantly decreased DENV protein at a half-maximal effective concentration (EC50) of 26.94 µM. Moreover, DENV RNA was dramatically decreased in cordycepin-treated Vero cells, indicating its effectiveness in inhibiting viral RNA replication. Via in silico molecular docking, the binding of cordycepin to DENV non-structural protein 5 (NS5), which is an important enzyme for RNA synthesis, at both the methyltransferase (MTase) and RNA-dependent RNA polymerase (RdRp) domains, was predicted. The results of this study demonstrate that cordycepin is able to inhibit DENV replication, which portends its potential as an anti-dengue therapy.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Replicação Viral / Desoxiadenosinas / Vírus da Dengue Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Replicação Viral / Desoxiadenosinas / Vírus da Dengue Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article